ACR适宜性标准®卵巢癌分期与随访:2025年更新
卵巢癌是美国女性第六大癌症死亡原因,影像在上皮性卵巢癌治疗前分期、治疗后反应评估和随访中起重要作用。增强CT是治疗前评估的主要手段,MRI、PET/CT及部分情况下的PET/MRI用于治疗前评估;CT和PET/CT也用于评估反应包括怀疑复发,MRI和PET/MRI用于特定病例。ACR适宜性标准是基于证据的指南,由多学科专家小组每年审查,采用GRADE等方法评估证据,文献缺乏或模棱两可时专家意见可作为主要证据来源。
要点
- 增强CT是卵巢癌治疗前评估的主要影像手段
- MRI、PET/CT及部分情况下的PET/MRI用于治疗前评估
- CT和PET/CT也用于评估治疗反应包括怀疑复发,MRI和PET/MRI用于特定病例
核心结论
- 影像在卵巢癌治疗前分期、治疗后反应评估和随访中起重要作用,准确的术前影像有助于确定合适的一线治疗。
研究设计与样本
- 美国放射学会适宜性标准,针对特定临床状况的循证指南,由多学科专家小组每年审查,采用GRADE等方法评估证据,采用RAND/UCLA适宜性方法确定影像和操作程序的适宜性。
诊断标准与关键数值
- 增强CT是卵巢癌治疗前评估的主要手段,MRI、PET/CT及部分情况下的PET/MRI用于治疗前评估。
- CT和PET/CT也用于评估治疗反应包括怀疑复发,MRI和PET/MRI用于特定病例。
临床应用与阅片要点
- 通过描述病变范围,影像可帮助判断能否实现最佳初次肿瘤细胞减灭术或是否需要新辅助化疗。
局限性
- 在同行评审文献缺乏或模棱两可的情况下,专家意见可能是制定推荐的主要证据来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Ovarian cancer remains the sixth most common cause of cancer mortality in women in the United States and is a leading cause of mortality among patients with gynecologic malignancies. Imaging plays an important role in pretreatment staging of epithelial ovarian cancers, the evaluation of posttreatment response, and follow-up. Accurate pretreatment imaging is integral to determine appropriate first-line therapy. By delineating the extent of disease, imaging can assist decision making regarding the likelihood of optimal primary cytoreduction or need for neoadjuvant chemotherapy when optimal cytoreduction is not felt to be achievable. Contrast-enhanced CT serves as a mainstay modality for the pretreatment assessment of ovarian cancer, with MRI, PET/CT, and, in some instances, PET/MRI used in the pretreatment setting. CT and PET/CT are also integral to assessing response, including in the suspected recurrence setting, with MRI and PET/MRI being used in select cases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Stein EB, Venkatesan AM, Akin EA, et al. ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update. J Am Coll Radiol. 2025. PMID: 41193052. doi:10.1016/j.jacr.2025.08.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。